Informing family members of individuals with Lynch syndrome: A guideline for clinical geneticists

Familial Cancer

Volumn 12, Issue 2, 2013, Pages 319-324

  Menko, Fred H ^a   Aalfs, Cora M ^b   Henneman, Lidewij ^a   Stol, Yrrah ^a   Wijdenes, Miranda ^a   Otten, Ellen ^c   Ploegmakers, Marleen M J ^d   Legemaate, Johan ^b   Smets, Ellen M A ^b   De Wert, Guido M W R ^e   Tibben, Aad ^f,g  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Dutch Association of Medical Specialists   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Duty to warn; Family communication; Genetic counselling; Hereditary cancer; Lynch syndrome

Indexed keywords

ARTICLE; CLINICAL GENETICS; GENETIC COUNSELING; HEALTH PERSONNEL ATTITUDE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DUTY TO WARN; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84880924487     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-013-9636-9     Document Type: Article

References (27)

1. Pylvänäinen K, Lehtinen T, Kellokumpu I, Järvinen H, Mecklin JP (2012) Causes of death of mutation carriers in Finnish Lynch syndrome families. Fam Cancer 11:467-471
2. Dutch Society for Clinical Genetics. Guideline on predictive DNA testing (Vereniging Klinische Genetica Nederland. Richtlijn voorspellend DNA-onderzoek). www.vkgn.org (in Dutch)
3. Christiaans I, Birnie E, Bonsel GJ et al (2008) Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet 16:1201-1207
4. Helderman-van den Enden AT, van den Bergen JC, Breuning MH et al (2011) Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level? Clin Genet 79:236-242
5. Stol YH, Menko FH, Westerman MJ, Janssens RM (2010) Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists. J Med Ethics 36:391-395
6. Godard B, Hulimann T, Letendre M et al (2006) Guidelines for disclosing genetic information to family members: from development to use. Fam Cancer 5:103-116
7. Offit K, Thom P (2007) Ethical and legal aspects of cancer genetic testing. Semin Oncol 35:435-443
8. Offit K, Thom P (2010) Ethicolegal aspects of cancer genetics. Cancer Treat Res 155:1-14
9. Nicolás P (2009) Ethical and juridical issues of genetic testing: a review of the international regulation. Crit Rev Oncol Hematol 69:98-107
10. Royal College of Physicians, Royal College of Pathologists and British Society for Human Genetics (2011) Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information, 2nd edn. Report of the Joint Committee on Medical Genetics. RCP, London
11. Lacroix M, Nycum G, Godard B, Knoppers B (2008) Should physicians warn patients' relatives of genetic risk? Can Med Assoc J 178:593-595
12. Ramsoekh D, van Leerdam ME, Tops CMJ et al (2007) The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP. Clin Genet 72:562-567
13. Chivers Seymour K, Addington-Hall J, Lucassen A et al (2010) What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-analysis of primary qualitative research. J Genet Couns 19:330-342
14. Wiseman M, Dancyger C, Michie S (2010) Communicating genetic risk information within families: a review. Fam Cancer 9:691-703
15. Suthers GK, Amstrong J, McCormack J, Trott D (2006) Letting the family know; balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 43:665-670
16. Aktan-Collan K, Haukkala A, Pylvänäinen K et al (2007) Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet 44:732-738
17. Evans DGR, Binchy A, Shenton A et al (2009) Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet 75:124-132
18. Forrest LE, Burke J, Bacic S et al (2008) Increased genetic counselling support improves communication of genetic information in families. Genet Med 10:167-172
19. Roshanai AH, Rosenquist R, Lampic C, Nordin K (2009) Does enhanced information at cancer genetic counselling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives? A randomized study. Acta Oncol 48:999-1009
20. Leenen HJJ, Gevers JKM, Legemaate J (2011) Handboek Gezondheidsrecht. Deel I. Rechten van mensen in de gezondheidszorg. Boom Juridische Uitgevers, Den Haag
21. de Wert G (2005) Cascade screening: whose information is it anyway? Eur J Hum Genet 13:397-398
22. Knoppers BM (2002) Genetic information and the family: are we our brother's keeper? Trends Biotechnol 20:85-86
23. Parker M, Lucassen A (2003) Concern for families and individuals in clinical genetics. J Med Ethics 29:70-73
24. Parker M, Lucassen A (2004) Genetic information: a joint account? BMJ 329:165-167
25. Newson AJ, Humphries SE (2005) Cascade testing in familial hypercholesterolaemia: how should family members be contacted? Eur J Hum Genet 13:401-408
26. Forrest LE, Delatycki MB, Skene L et al (2007) Communicating genetic information in families - a review of guidelines and position papers. Eur J Hum Genet 15:612-618
27. Grol R, Buchan H (2006) Clinical guidelines: what can we do to increase their use? Med J Aust 185:301-302